Pharmacosynchrony is the application of innovative clinical, analytic, and technologic pharmacy solutions to drive improved care coordination and higher-quality, more patient-centered care.
David Calabrese, RPh, MHP
Advertisement
Articles by David Calabrese, RPh, MHP
Evaluating the relationships between chronic kidney disease and cardiovascular disease and strategies to improve outcomes.
Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
Advertisement
Latest Updated Articles
- Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits Program
Published: October 27th 2010 | Updated:
- Improving Outcomes in Chronic Kidney Disease: Optimizing Management of Cardiovascular Diseases
Published: December 8th 2011 | Updated:
- Pharmacosynchrony: Road Map to Transformation in Pharmacy Benefit Management
Published: April 15th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
4
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
5
